162 related articles for article (PubMed ID: 11327632)
1. The release of the substrate for xanthine oxidase in hypertensive patients was suppressed by angiotensin converting enzyme inhibitors and alpha1-blockers.
Ohtahara A; Hisatome I; Yamamoto Y; Furuse M; Sonoyama K; Furuse Y; Hamada T; Katoh M; Watanabe M; Kinugawa T; Ogino K; Igawa O; Shimomura T; Murakami F; Yamamoto T; Shigemasa C
J Hypertens; 2001 Mar; 19(3 Pt 2):575-82. PubMed ID: 11327632
[TBL] [Abstract][Full Text] [Related]
2. A vasodilating β1 blocker celiprolol inhibits muscular release of uric acid precursor in patients with essential hypertension.
Mizuta E; Utami SB; Ohtahara A; Endo S; Mishima M; Hasegawa A; Yamada K; Kato M; Yamamoto K; Ogino K; Ninomiya H; Miyazaki S; Hamada T; Taniguchi SI; Cheng J; Hisatome I
Horm Metab Res; 2013 Jan; 45(1):69-73. PubMed ID: 22893261
[TBL] [Abstract][Full Text] [Related]
3. Effect of Antihypertensive Drugs on Uric Acid Metabolism in Patients with Hypertension: Cross-Sectional Cohort Study.
Ueno S; Hamada T; Taniguchi S; Ohtani N; Miyazaki S; Mizuta E; Ohtahara A; Ogino K; Yoshida A; Kuwabara M; Yoshida K; Ninomiya H; Kotake H; Taufiq F; Yamamoto K; Hisatome I
Drug Res (Stuttg); 2016 Dec; 66(12):628-632. PubMed ID: 27643410
[No Abstract] [Full Text] [Related]
4. [Idiopathic hyperuricemia with overproduction of uric acid].
Mizuta E; Igawa O; Hisatome I
Nihon Rinsho; 2008 Apr; 66(4):675-8. PubMed ID: 18409513
[TBL] [Abstract][Full Text] [Related]
5. Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia.
Kohagura K; Tana T; Higa A; Yamazato M; Ishida A; Nagahama K; Sakima A; Iseki K; Ohya Y
Hypertens Res; 2016 Aug; 39(8):593-7. PubMed ID: 27075830
[TBL] [Abstract][Full Text] [Related]
6. Reversal of an unfavorable effect of hydrochlorothiazide compared to angiotensin converting enzyme inhibitor on serum uric acid and oxypurine levels by estrogen-progestin therapy in hypertensive postmenopausal women.
Posadzy-Malaczynska A; Rajpold K; Woznicka-Leskiewicz L; Marcinkowska J
Curr Med Res Opin; 2019 Oct; 35(10):1687-1697. PubMed ID: 31033362
[No Abstract] [Full Text] [Related]
7. [Value of oxypurines and uric acid in plasma, renal excretion of oxypurines and uric acid as well as plasma adenosine deaminase and AMP deaminase activity in patients with essential hypertension].
Tykarski A; Głuszek J; Banaszak F
Pol Arch Med Wewn; 1993 Mar; 89(3):223-9. PubMed ID: 8327372
[TBL] [Abstract][Full Text] [Related]
8. Associations of plasma uric acid and purine metabolites with blood pressure in children: the KOALA Birth Cohort Study.
Scheepers LE; Boonen A; Pijnenburg W; Bierau J; Staessen JA; Stehouwer CD; Thijs C; Arts IC
J Hypertens; 2017 May; 35(5):982-993. PubMed ID: 28355168
[TBL] [Abstract][Full Text] [Related]
9. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA.
Schmidt A; Gruber U; Böhmig G; Köller E; Mayer G
Nephrol Dial Transplant; 2001 May; 16(5):1034-7. PubMed ID: 11328912
[TBL] [Abstract][Full Text] [Related]
10. Enzymes involved in purine metabolism--a review of histochemical localization and functional implications.
Moriwaki Y; Yamamoto T; Higashino K
Histol Histopathol; 1999 Oct; 14(4):1321-40. PubMed ID: 10506947
[TBL] [Abstract][Full Text] [Related]
11. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
13. Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive subjects.
Newaz MA; Adeeb NN; Muslim N; Razak TA; Htut NN
Clin Exp Hypertens; 1996 Nov; 18(8):1035-50. PubMed ID: 8922344
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of uridine correlate with blood pressure and indicators of myogenic purine degradation and insulin resistance in hypertensive patients.
Hamada T; Mizuta E; Yanagihara K; Kaetsu Y; Sugihara S; Sonoyama K; Yamamoto Y; Kato M; Igawa O; Shigemasa C; Inokuchi T; Yamamoto T; Shimada T; Ohtahara A; Ninomiya H; Hisatome I
Circ J; 2007 Mar; 71(3):354-6. PubMed ID: 17322634
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricemia and xanthine oxidase in preeclampsia, revisited.
Many A; Hubel CA; Roberts JM
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):288-91. PubMed ID: 8572024
[TBL] [Abstract][Full Text] [Related]
16. Relationship of oxypurine release to contractile failure in dinitrophenol-treated rat skeletal muscle.
Majumdar R; Cwik VA; Solonynko G; Brooke MH
Acta Physiol Scand; 1993 Nov; 149(3):249-55. PubMed ID: 8310832
[TBL] [Abstract][Full Text] [Related]
17. Substrate orientation and catalytic specificity in the action of xanthine oxidase: the sequential hydroxylation of hypoxanthine to uric acid.
Cao H; Pauff JM; Hille R
J Biol Chem; 2010 Sep; 285(36):28044-53. PubMed ID: 20615869
[TBL] [Abstract][Full Text] [Related]
18. Excessive purine degradation during semi-ischemic forearm test in patients with diabetes mellitus.
Tanaka Y; Hisatome I; Kinugawa T; Tanaka H; Tomikura Y; Ando F; Matsuura T; Igawa G; Matsubara K; Yamamoto Y; Yamawaki M; Yamamoto R; Ogino K; Igawa O; Ikeda T; Shigemasa C; Takeda A
Intern Med; 2003 Sep; 42(9):788-92. PubMed ID: 14518663
[TBL] [Abstract][Full Text] [Related]
19. The effect of infusing hypoxanthine or xanthine on hypoxic-ischemic brain injury in rabbits.
Mink R; Johnston J
Brain Res; 2007 May; 1147():256-64. PubMed ID: 17335786
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen.
Ogura J; Kuwayama K; Sasaki S; Kaneko C; Koizumi T; Yabe K; Tsujimoto T; Takeno R; Takaya A; Kobayashi M; Yamaguchi H; Iseki K
Biochem Pharmacol; 2015 Sep; 97(1):89-98. PubMed ID: 26119820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
